Manufacturer record
Aban Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Aban Pharmaceuticals (Kerala) were declared Not of Standard Quality between September 2023 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 25010040, Diclofenac Potass um & Serratiopeptidase Tablets (exp Nov 2027). SDTL, Andhra Pradesh (state lab) found it not of standard quality: The Sample does not confirm to the standards of Disintegration Test mentioned under General Requirements of IP as per Standards for Patent. Listed in the August 2026 alert.
Records by type
8 records linked to Aban Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Potass um & Serratiopeptidase Tablets | Batch 25010040Mfg Oct 2025 · Exp Nov 2027 | The Sample does not confirm to the standards of Disintegration Test mentioned under General Requirements of IP as per Standards for Patent and Proprietary Medicines in Schedule-V of Drugs and Cosmetics Act, 1940 and Rules there under.Disintegration | SDTL, Andhra PradeshState lab | Aug 2026 |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup | Batch S-199/25Mfg Jul 2025 · Exp Jun 2027 | Dextromethorphan Hydrobromide contentOther | FDL, VadodaraState lab | Jun 2026 |
| Paracetamol Tablets IP | Batch 2506006Mfg Jun 2025 · Exp May 2028 | The samole does not comply with IP requirment for the Dissolution test.Dissolution | FDAL, MumbaiState lab | Apr 2026 |
| Paracetamol Tablets I.P. 650 mg | Batch 2309026Mfg Sep 2023 · Exp Aug 2026 | The sample does not conform to standard quality in respect of the test for Dissolution performed.Dissolution | SDTL Govt. of Tripura, AgartalaState lab | Jan 2026 |
| Omeprazole Capsule IP 20 mg | Batch 153/25Mfg Jan 2025 · Exp Dec 2026 | Dissolution (Buffer satage)Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Paracetamol Tablets I.P 650 mg (Alpa-650 Tablets) | Batch 2501032Mfg Jan 2025 · Exp Dec 2027 | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Levocetirizin Hydrochloride &Montelukast Sodium Tablets IP (Montefirst- LC) | Batch 2405097Mfg May 2024 · Exp Apr 2026 | Test for Dissolution of Levocetirizine Hydrochloride and MontelukastDissolution | State Lab KarnatakaState lab | Dec 2024 |
| LEVOCETIRIZINE HYDROCHLORIDE TABLETS I.P. 5 mg. (Alocet) | Batch 2303117Mfg Mar 2023 · Exp Feb 2026 | Assay /Content of Levocetirizin HydrochlorideAssay | RDTL GuwahatiState lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.